International Myeloma Foundation — Receipts Report
Client
Lobbying client · LD-2 disclosures
International Myeloma Foundation
California
125 filings from 7 registrants · 2008–2026 · latest filed May 2, 2026
Reported on its behalf
$5.1M
every LD-2 on file
Its own filed spend
$3.1M
lobbying for itself
Fees to outside firms
$1.9M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: international-myeloma-foundation.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
25 filings
$1.3M on those filings
Medical/Disease Research/Clinical Labs
MED
18 filings
$691K on those filings
Veterans
VET
12 filings
$577K on those filings
Gaming/Gambling/Casino
GAM
1 filing
$51K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
113th Congress
Cancer Drug Coverage Parity Act of 2013
17 filingsthrough 2014
S. 2039118th CongressCancer Drug Parity Act of 202316 filingsthrough 2024
S. 741116th CongressCancer Drug Parity Act of 201916 filingsthrough 2020
H.R. 2477113th CongressPlanning Actively for Cancer Treatment (PACT) Act of 201315 filingsthrough 2014
H.R. 2746112th CongressCancer Drug Coverage Parity Act of 201112 filingsthrough 2012
H.R. 2827113th CongressPart D Beneficiary Appeals Fairness Act11 filingsthrough 2014
H.R. 543113th CongressBlue Water Navy Vietnam Veterans Act of 201311 filingsthrough 2014
H.R. 1409115th CongressCancer Drug Parity Act of 201710 filingsthrough 2018
H.R. 1491113th CongressTo authorize the Administrator of the National Oceanic and Atmospheric Administration to provide certain funds to eligible entities for activities undertaken to address the marine debris impacts of the March 2011 Tohoku earthquake and subsequent tsunami, and for other purposes.10 filingsthrough 2014
S. 1566114th CongressCancer Drug Coverage Parity Act of 20159 filingsthrough 2016
H.R. 2410113th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20149 filingsthrough 2014
H.R. 2366111th CongressNamed in the filings; no matching bill record on file.9 filingsthrough 2010
H.R. 9747119th CongressWelcome Back to the Health Care Workforce Act8 filingsthrough 2026
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
22 filings
through 2015
Jeremy ScottFaegre Drinker Biddle & Reath LLPCovered position: Staff Asst./Leg. Corr., Senator Mike DeWine21 filingsthrough 2019
Anna Kelley SidorowiczInternational Myeloma Foundation18 filingsthrough 2019
Jeremy ScottCavarocchi Ruscio Dennis Associates, L.L.C.15 filingsthrough 2024
Phil GingreyFaegre Drinker Biddle & Reath LLPCovered position: United States Congressman to the 11th District of Georgia, 2003-201515 filingsthrough 2019
Jonathan M. HeppenFaegre Drinker Biddle & Reath LLP15 filingsthrough 2019
NICHOLAS G CAVAROCCHI srCavarocchi Ruscio Dennis Associates, L.L.C.15 filingsthrough 2014
Jennifer Rachel LeibCavarocchi Ruscio Dennis Associates, L.L.C.Covered position: Policy Fellow, NIH/NHGRI Office of the Director12 filingsthrough 2015
Taylor PattonInternational Myeloma Foundation10 filingsthrough 2016
